Park Ha Biological Technology (BYAH) Receivables - Net (2023 - 2026)

Park Ha Biological Technology has reported Receivables - Net for 4 years, with the latest figure at -$3.5 million in Q2 2026.

• On a quarterly basis, Receivables - Net fell 453.36% year-over-year to -$3.5 million in Q2 2026; TTM through Apr 2026 was -$3.5 million, a 453.36% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, down 12.41% from the prior year.
• Receivables - Net was -$3.5 million for Q2 2026 at Park Ha Biological Technology, down from $255844.0 in the prior quarter.
• The five-year high for Receivables - Net was $996605.0 in Q2 2025, with the low at -$3.5 million in Q2 2026.
• Average Receivables - Net over 4 years is -$232277.0, with a median of $361735.0 recorded in 2023.
• The sharpest annual moves came in 2024 and 2026: Receivables - Net soared 106.23% in 2024, then plunged 453.36% in 2026.
• Over 4 years, Receivables - Net stood at $361735.0 in 2023, then jumped by 106.23% to $745992.0 in 2024, then tumbled by 65.7% to $255844.0 in 2025, then tumbled by 1476.45% to -$3.5 million in 2026.
• The last three Receivables - Net figures came in at -$3.5 million (Q2 2026), $255844.0 (Q4 2025), and $996605.0 (Q2 2025), per Business Quant data.